Streptococcus agalactiae (Group B Streptococcus)

Principles and Practice of Pediatric Infectious Diseases, Fourth Edition

Volumn , Issue , 2012, Pages 707-712.e2

  Edwards, Morven S ^a,b   Baker, Carol J ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c Woman's Hospital of Texas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891688376     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2702-9.00121-5     Document Type: Chapter

References (60)

1. P Lauer, CD Rinaudo, M Soriani, et al. (2005) Genome analysis reveals pili in group B Streptococcus. Science 309 105.
2. HC Maisey, M Hensler, V Nizet, et al. (2007) Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol 189 1464-1467.
3. MJ Baron, GR Bolduc, MB Goldberg, et al. (2004) Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J Biol Chem 279 24714-24723.
4. M Soriani, I Santi, A Taddei, et al. (2006) Group B Streptococcus crosses human epithelial cells by a paracellular route. J Infect Dis 193 241-250.
5. V Nizet, RL Gibson, EY Chi, et al. (1996) Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 64 3818-3826.
6. RL Gibson, V Nizet and CE Rubens (1999) Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res 45 626-634.
7. Sørensen UBS, Poulsen K, Ghezzo C, et al. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. mBio 2010;1:e00178–10.
8. AF Carlin, S Uchiyama, YC Chang, et al. (2009) Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune system. Blood 113 3333-3336.
9. AF Carlin, YC Chang, T Areschoug, et al. (2009) Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J Exp Med 206 1691-1699.
10. CJ Baker and DL Kasper (1976) Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 294 753-756.
11. CJ Baker, FF Barrett, RC Gordon, et al. (1973) Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr 82 724-729.
12. FJD Noya, MA Rench, TG Metzger, et al. (1987) Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis 155 1135-1144.
13. Centers for Disease Control and Prevention (2011) Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, provisional-2010. http://www.cdc.gov/abcs/reports-findings/survreports/gbs10.pdf
14. F-YC Lin, LE Weisman, J Troendle, et al. (2003) Prematurity is the major risk factor for late-onset group B Streptococcus disease. J Infect Dis 188 267-271.
15. P Yagupsky, MA Menegus and KR Powell (1991) The changing spectrum of group B streptococcal disease in infants: an eleven-year experience in a tertiary care hospital. Pediatr Infect Dis J 10 801-808.
16. ME Hickman, MA Rench, P Ferrieri, et al. (1999) Changing epidemiology of group B streptococcal colonization. Pediatrics 104 203-209.
17. MA Rench and CJ Baker (1993) Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr 122 638-640.
18. CR Phares, R Lynfield, MM Farley, et al. (2008) Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA 299 2056-2065.
19. JK MacFarquhar, TF Jones, AM Woron, et al. (2010) Outbreak of late-onset group B Streptococcus in a neonatal intensive care unit. Am J Infect Control 38 283-288.
20. MS Edwards, V Nizet, CJ Baker (2011) Group B streptococcal infections. JS Remington, JO Klein, CB Wilson, et al., (Eds) Infectious Diseases of the Fetus and Newborn Infant 7th ed Philadelphia: Elsevier Saunders 419-469.
21. LE Weisman, BJ Stoll, DF Cruess, et al. (1992) Early-onset group B streptococcal sepsis: a current assessment. J Pediatr 121 428-433.
22. SJ Schrag, S Zywicki, MM Farley, et al. (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342 15-20.
23. HD Davies, J LeBlanc, R Bortolussi, et al. (1999) The Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of neonatal group B streptococcal infections in Canada. Paediatr Child Health 4 257.
24. NR Payne, BA Burke, DL Day, et al. (1988) Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatr Infect Dis J 7 836-847.
25. MS Edwards, MA Rench, AAM Haffar, et al. (1985) Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr 106 717-722.
26. F Levent, CJ Baker, MA Rench, et al. (2010) Early outcomes of group B streptococcal meningitis in the 21st century. Pediatr Infect Dis J 29 1009-1012.
27. MS Edwards, CJ Baker, ML Wagner, et al. (1978) An etiologic shift in infantile osteomyelitis: the emergence of the group B Streptococcus. J Pediatr 93 578-583.
28. B Siskind, P Galliguez and ER Wald (1975) Group B beta hemolytic streptococcal osteomyelitis/purulent arthritis in neonates: report of three cases. J Pediatr 87 659.
29. IA Memon, NM Jacobs, TF Yeh, et al. (1979) Group B streptococcal osteomyelitis and septic arthritis: its occurrence in infants less than 2 months old. Am J Dis Child 133 921-923.
30. TH Rand (1988) Group B streptococcal cellulitis in infants: a disease modified by prior antibiotic therapy or hospitalization? Pediatrics 81 63-65.
31. CJ Baker (1982) Group B streptococcal cellulitis-adenitis in infants. Am J Dis Child 136 631-633.
32. AK Ansong, PB Smith, DK Benjamin, et al. (2009) Group B streptococcal meningitis: Cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Early Hum Development 85 S5-S7.
33. KM Puopolo, LC Madoff and EC Eichenwald (2005) Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115 1240-1246.
34. MK Van Dyke, CR Phares, R Lynfield, et al. (2009) Evaluation of universal antenatal screening for group B Streptococcus. N Engl J Med 360 2626-2636.
35. DN Greenberg and BA Yoder (1990) Changes in the differential white blood cell count in screening for group B streptococcal sepsis. Pediatr Infect Dis J 9 886-889.
36. TB Newman, KM Puopolo, S Wi, et al. (2010) Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 126 903-909.
37. FDA Alert (1997) Safety alert regarding risk of misdiagnosis of group B streptococcal infection. JAMA 277 1343.
38. N Nagano, Y Nagano, K Kimura, et al. (2008) Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52 4258-4267.
39. S Dahesh, ME Hensler, NM Van Sorge, et al. (2008) Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob Agents Chemother 52 2915-2918.
40. CJ Baker (1987) Antibiotic susceptibility testing in the management of an infant with group B streptococcal meningitis. Pediatr Infect Dis J 6 1073.
41. LE Weisman, BJ Stoll, TJ Kueser, et al. (1992) Intravenous immune globulin therapy for early-onset sepsis in premature neonates. J Pediatr 121 434-443.
42. CA Friedman, DF Wender, DM Temple, et al. (1990) Intravenous gamma globulin as adjunct therapy for severe group B streptococcal disease in the newborn. Am J Perinatol 7 1-4.
43. RG Faix and SM Donn (1985) Association of septic shock caused by early-onset group B streptococcal sepsis and periventricular leukomalacia in the preterm infant. Pediatrics 76 415-419.
44. R Libster, MS Edwards, F Levent, et al. (2011) Long-term outcomes of group B streptococcal meningitis. Infectious Diseases Society of America, 49th Annual Meeting Abst. no. 30921
45. PA Green, KV Singh, BE Murray, et al. (1994) Recurrent group B streptococcal infections in infants: clinical and microbiologic aspects. J Pediatr 125 931-938.
46. KM Zangwill, A Schuchat and JD Wenger (1992) Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR 41 25-32.
47. EH Moylett, M Fernandez, MA Rench, et al. (2000) A 5-year review of recurrent group B streptococcal disease: lessons from twin infants. Clin Infect Dis 30 282-287.
48. M Fernandez, MA Rench, EA Albanyan, et al. (2001) Failure of rifampin to eradicate group B streptococcal colonization in infants. Pediatr Infect Dis J 20 371-376.
49. KM Boyer and SP Gotoff (1986) Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 314 1665-1669.
50. Committee on Infectious Diseases and Committee on Fetus and Newborn of the American Academy of Pediatrics (1992) Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 90 775-778.
51. Centers for Disease Control and Prevention (1996) Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 45 1-24.
52. SJ Schrag, ER Zell, R Lynfield, et al. (2002) A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 347 233-239.
53. Centers for Disease Control and Prevention (2002) Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR 51(RR-11), 1-22.
54. ACOG Committee Opinion (2002) Number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol 100 1405-1412.
55. Centers for Disease Control and Prevention (2010) Prevention of perinatal group B streptococcal disease revised guidelines from CDC 2010. MMWR 59(RR-10), 1-31.
56. M Pylipow, M Gaddis and JS Kinney (1994) Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. Pediatrics 93 631-635.
57. AJ Blaschke, LS Pulver, EK Korgenski, et al. (2010) Clindamycin-resistant group B streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease. J Pediatr 156 501-503.
58. P Bromberger, JM Lawrence, D Braun, et al. (2000) The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 106 244-250.
59. CV Towers, PJ Rumney, SF Minkiewicz, et al. (1999) Incidence of intrapartum maternal risk factors for identifying neonates at risk for early-onset group B streptococcal sepsis: a prospective study. Am J Obstet Gynecol 181 1197-1202.
60. CM Healy and CJ Baker (2006) Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis 19 271-276.